SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors upcoming FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the November 22 target date and the companys amended application emphasizing upper-limb function data. Bullish traders interpret the longer-term data, rare-disease policy discussions and recent commercial hiring as encouraging signs, while skeptics cite prior FDA concerns and say approval remains uncertain.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention for its breakout ahead of the expected Q3 earnings report, with traders focused on BRIUMVIs growth and possible further upside. Buyout and short-squeeze chatter is prominent but speculative; some traders instead attribute the move to earnings expectations and the companys commercial momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could fall after early 2027 has fueled a sharp selloff and concern about future pricing and revenue. Traders disagree over whether the warning signals sustained pressure or is only a preliminary estimate, pointing to CMSs more stable outlook while criticizing CorMedixs lack of clarification.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp Nasdaq selloff tied to weakness in technology and semiconductor stocks, with traders debating whether concerns about AI spending and earnings justify more downside or whether the decline is an oversold dip to buy. The late-session rebound prompted some dip-buying optimism, but bearish traders continued to warn that the correction may not be over.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS REGAL Phase 3 leukemia trial reached its prespecified event threshold, triggering final analysis and putting the GPS survival readout in focus. Traders are sharply divided over whether GPS will show a benefit or whether control-arm outcomes and trial assumptions could undermine the bull case, amid volatile trading and speculation about short positioning.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigens PAPZIMEOS commercial launch and stronger-than-expected quarterly results, including a move to profitability, are driving bullish discussion about its growth prospects. Traders also debate whether potential INO-3107 competition could challenge PAPZIMEOS and whether heavy short interest is amplifying the stocks moves.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

A reported major Binance security breach and temporary withdrawal suspension have fueled Bitcoin selling and concerns about crypto exchange security. Traders disagree over whether the incident signals broader risk or is isolated to Binance, with some viewing the pullback as a buying opportunity and others warning of further downside.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is caught in a sharp semiconductor and AI-stock selloff, with traders citing its rich valuation and questioning whether AI demand can support the growth priced in. Some see the drop as an overdone sector-driven correction and are buying the dip, while others expect further downside.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly report is fueling concern about slowing ad growth, analyst target cuts, and weakness across advertising-related stocks. Traders debate whether the decline reflects deteriorating prospects or has overshot the companys growth and cash-generation fundamentals, with earnings seen as a key test.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

Silvers sharp selloff, amid inflation concerns and expectations of higher interest rates, is driving attention to SLV. Traders are split between calling the decline an oversold buying opportunity and warning that selling may continue, with some blaming market manipulation without evidence.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: Molson Coors Brewing (TAP) Q3 Earnings Expected to Decline

Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MGP (MGPI) Q3 Earnings and Revenues Beat Estimates

MGP (MGPI) delivered earnings and revenue surprises of +14.71% and +1.91%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Pump-Pain Squeezes Convenience Store Spending: Citi Says "More Subdued" Mood Among Beverage Companies

Pump-Pain Squeezes Convenience Store Spending: Citi Says "More Subdued" Mood Among Beverage Companies

 Our reporting this year has shown how skyrocketing gasoline and diesel prices at the pump are reshaping consumer spending habits at convenience stores and gas stations.?

As fuel...

Want Passive Income for Life? Here Are 4 Beaten-Down Consumer Stocks to Buy Now.

Key PointsGeneral Mills, Molson Coors, Hormel Foods, and Clorox have a combined dividend history stretching well over two centuries...

Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?

Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Can Monaco's Expanding Footprint Drive Molson Coors' Revenues?

TAP is expanding Monaco Cocktails' reach beyond five key states, tapping into RTD spirits demand and new distribution channels to drive revenue growth.

Molson Coors Canada Q2 2026 Earnings Call: Complete Transcript

On Thursday, Molson Coors Canada (TSX:TPX) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This transcript is brought to you by Benzinga APIs. For real-timeread more...

Zacks Industry Outlook Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors 

Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors have been highlighted in this Industry Outlook article.


5 Alcohol Stocks to Watch as Innovation Fuels Industry Growth

Beverages - Alcohol industry players are tapping RTD cocktails, and low- and no-alcohol innovation, while tariffs and softer consumption could pressure costs, volumes, pricing power and industry margins.

Molson Coors Beverage Co. is a holding company, which engages in the production and sale of beer. It operates through the Americas and EMEA and APAC geographical segments. The Americas segment imports, markets, distributes, and sells owned brands and partner brands and licensed brands in the U.S., Canada and various countries in Latin America. The EMEA and APAC segment consists of the production, marketing, and sales of primary brands as well as other owned and licensed brands in Bulgaria, Croatia, Czech Republic, Hungary, Montenegro, the Republic of Ireland, Romania, Serbia, the U.K., various other European countries and certain countries within the Middle East, Africa and Asia Pacific regions. The company was founded in 1786 and is headquartered in Golden, CO.

Molson Coors Beverage Company - Ordinary Shares - Class B

Molson Coors Announces Workforce Reduction, Nearly 400 Salaried Positions To Be Eliminated

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Molson Coors said the restructuring plan would result in the elimination of nearly 400 salaried positions by the end of December 2025.</li><li>The company said it was focusing on returning to growth, concentrating on both its beer portfolio and its expansion into adjacent categories.</li><li>Molson Coors currently expects to incur certain related charges in the range of $35 million to $50 million as part of the restructuring.</li></ul>Molson Coors Beverage Company (TAP) said on Monday that it plans to reduce about 9% of the company’s Americas business salaried workforce as part of a corporate restructuring plan.The company said that this would result in the elimination of nearly 400 salaried positions by the end of December 2025 and includes hundreds of salaried positions that were already open from role prioritization efforts put in place earlier this year, and those who may be granted voluntary severance as part of this restructuring.Shares of Molson Coors were down nearly 1% in early trading.&nbsp;<h2 class="st-heading-2">Why Is The Company Undertaking A Restructuring Plan?</h2>Molson Coors said that the restructuring aims to enhance its ability to reinvest in its business, including its priority brands and “must-win initiatives.”As part of the plan, the company said it was focusing on returning to growth, concentrating on both its beer portfolio and its expansion into adjacent categories, such as premium mixers, non-alcoholic beverages, and energy drinks.Several beer and wine companies in the U.S. are seeing a slowdown in demand for alcohol as consumers become cautious of price increases in the economy and are prioritising buying essentials over expensive purchases.&nbsp;<h2 class="st-heading-2">What Are The Restructuring Charges?</h2>The company said as part of the restructuring, Molson Coors currently expects to incur certain related charges in the range of $35 million to $50 million, substantially all of which relate primarily to cash severance payments and post-employment benefits to be incurred in the fourth quarter of 2025.Molson Coors said the cash payments are expected to be made over the next twelve months.<h2 class="st-heading-2">What Is The CEO Saying?</h2>President and Chief Executive Officer Rahul Goyal stated that the firm has made progress on its transformation journey, but given the environment, it must transform even faster. He added that to “win with our customers and consumers” and return to growth, the company must move with “urgency and make bolder decisions.”<blockquote>“We are moving quickly and intentionally on a long-term, achievable strategy that continues our journey to become a total beverage company and that we believe puts us on the path to sustainable growth.”&nbsp;-Rahul Goyal, CEO, Molson Coors&nbsp;</blockquote><a href="https://stocktwits.com/symbol/TAP">Shares of Molson Coors</a> have fallen nearly 18% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/greenlane-holdings-stock-soars-110-m-crypto-treasury-initiative-with-berachain/ch6CD7mR3YF">Greenlane Holdings Stock Soars 27% On $110M Crypto Treasury Initiative With Berachain</a>

In this photo illustration, the Molson Coors Beverage logo is seen displayed on a smartphone screen.

Molson Coors said the restructuring plan would result in the elimination of nearly 400 salaried positions by the end of December 2025.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$40.12
Prev Close	$39.21
Open	$40.03
Dividend Yield	4.03%
50-Day Moving Average	$39.02
Beta	0.21
Avg. Volume	5.49M
PE Ratio	-3.40

52-Week High	$54.82
52-Week Low	$35.52
Market Capitalization	$7.34B
EPS (Annual)	-$10.75
Price to Book	0.69
Revenue Per Employee	$687,703.70

Feed

News

Sentiment

Earnings

Fundamentals

Info

TAP Fundamentals